Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) - XML Representation - Evidence Based Medicine on FHIR Implementation Guide v1.0.0-ballot3

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
: Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)

Raw xml | Download

<Citation xmlns="http://hl7.org/fhir">
  <id value="58"/>
  <meta>
    <versionId value="32"/>
    <lastUpdated value="2025-10-13T16:59:33.089Z"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><p class="res-header-id"><b>Generated Narrative: Citation 58</b></p><a name="58"> </a><a name="hc58"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 32; Last updated: 2025-10-13 16:59:33+0000; Language: en</p></div><p><b>ArtifactPublicationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}">Active</span></p><p><b>url</b>: <a href="https://fevir.net/resources/Citation/58">https://fevir.net/resources/Citation/58</a></p><p><b>identifier</b>: FEvIR Object Identifier/58</p><p><b>title</b>: Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</p><p><b>status</b>: Active</p><p><b>date</b>: 2022-01-10 13:29:15+0000</p><p><b>author</b>: Brian S. Alper: </p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>
</div><h3>UseContexts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style="display: none">*</td><td><a href="http://terminology.hl7.org/7.1.0/CodeSystem-citation-classification-type.html#citation-classification-type-fevir-platform-use">Citation Classification Type: fevir-platform-use</a> (FEvIR Platform Use)</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/citation-artifact-classifier fhir-resource}">FHIR Resource</span></td></tr></table><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><h3>Summaries</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Style</b></td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/citation-summary-style comppub}">Computable Publishing</span></td><td><div><p>14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors:  Brian S. Alper,  Joanne Dehnbostel,  Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55.</p>
</div></td></tr></table><h3>RelatesTos</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Target[x]</b></td></tr><tr><td style="display: none">*</td><td>Derived From</td><td><a href="Evidence-55.html">14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</a></td></tr></table><blockquote><p><b>citedArtifact</b></p><p><b>identifier</b>: FEvIR Object Identifier/55</p><p><b>dateAccessed</b>: 2021-03-13</p><h3>StatusDates</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Activity</b></td><td><b>Actual</b></td><td><b>Period</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type created}">Created</span></td><td>true</td><td>?? --&gt; 2020-12-17</td></tr></table><h3>Titles</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/title-type primary}">Primary title</span></td><td><div><p>14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY).</p>
</div></td></tr></table><h3>Abstracts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Text</b></td><td><b>Copyright</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-abstract-type primary-human-use}">Primary human use</span></td><td><div><p>COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis</p>
</div></td><td><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div></td></tr></table><blockquote><p><b>publicationForm</b></p><h3>PublishedIns</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Title</b></td><td><b>Publisher</b></td><td><b>PublisherLocation</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/published-in-type D019991}">Database</span></td><td>Fast Evidence Interoperability Resources (FEvIR) Platform</td><td>Computable Publishing LLC</td><td>Ipswich, MA, USA</td></tr></table><p><b>lastRevisionDate</b>: 2020-12-21</p><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div></blockquote><blockquote><p><b>webLocation</b></p><p><b>classifier</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/artifact-url-classifier json}">JSON</span>, <span title="Codes:{http://terminology.hl7.org/CodeSystem/artifact-url-classifier computable-resource}">Computable resource</span></p><p><b>url</b>: <a href="https://fevir.net/resources/Evidence/55">https://fevir.net/resources/Evidence/55</a></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type knowledge-artifact-type}">Knowledge Artifact Type</span></p><p><b>classifier</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/citation-artifact-classifier fhir-resource}">FHIR Resource</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title="Codes:">fhir-resource</span></p><p><b>classifier</b>: <span title="Codes:{http://hl7.org/fhir/fhir-types Evidence}">Evidence</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title="Codes:">defined-in-text</span></p><p><b>classifier</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}">remdesivir</span>, <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}">COVID-19</span>, <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}">pharmaceutical treatment</span></p></blockquote><blockquote><p><b>contributorship</b></p><p><b>complete</b>: true</p><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href="#hc58/contributor0">Practitioner Brian S. Alper </a></p><p><b>forenameInitials</b>: BS</p><p><b>affiliation</b>: Computable Publishing LLC</p><p><b>contributionType</b>: <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type conceptualization}">Conceptualization</span>, <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type data-curation}">Data curation</span>, <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type supervision}">Supervision</span></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/contributor-role author}">Author/Creator</span></p><p><b>correspondingContact</b>: true</p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href="#hc58/contributor1">Practitioner Joanne Dehnbostel </a></p><p><b>forenameInitials</b>: J</p><p><b>affiliation</b>: Computable Publishing LLC</p><p><b>contributionType</b>: <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type formal-analysis}">Formal analysis</span>, <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type data-curation}">Data curation</span></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/contributor-role author}">Author/Creator</span></p><p><b>correspondingContact</b>: false</p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href="#hc58/contributor2">Practitioner Khalid Shahin </a></p><p><b>forenameInitials</b>: K</p><p><b>affiliation</b>: Computable Publishing LLC</p><p><b>contributionType</b>: <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type software}">Software</span></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/contributor-role author}">Author/Creator</span></p><p><b>correspondingContact</b>: false</p></blockquote></blockquote></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Practitioner #contributor0</b></p><a name="58/contributor0"> </a><a name="hc58/contributor0"> </a><p><b>identifier</b>: <code>https://orcid.org/</code>/0000-0003-4300-4928</p><p><b>name</b>: Brian S. Alper </p><p><b>telecom</b>: <a href="mailto:balper@computablepublishing.com">balper@computablepublishing.com</a></p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Practitioner #contributor1</b></p><a name="58/contributor1"> </a><a name="hc58/contributor1"> </a><p><b>name</b>: Joanne Dehnbostel </p><p><b>telecom</b>: <a href="mailto:jdehnbostel@computablepublishing.com">jdehnbostel@computablepublishing.com</a></p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Practitioner #contributor2</b></p><a name="58/contributor2"> </a><a name="hc58/contributor2"> </a><p><b>name</b>: Khalid Shahin </p><p><b>telecom</b>: <a href="mailto:kshahin@computablepublishing.com">kshahin@computablepublishing.com</a></p></blockquote></div>
  </text>
  <contained>
    <Practitioner>
      <id value="contributor0"/>
      <identifier>
        <system value="https://orcid.org/"/>
        <value value="0000-0003-4300-4928"/>
        <assigner>
          <display value="ORCID"/>
        </assigner>
      </identifier>
      <name>
        <family value="Alper"/>
        <given value="Brian S."/>
      </name>
      <telecom>
        <system value="email"/>
        <value value="balper@computablepublishing.com"/>
      </telecom>
    </Practitioner>
  </contained>
  <contained>
    <Practitioner>
      <id value="contributor1"/>
      <name>
        <family value="Dehnbostel"/>
        <given value="Joanne"/>
      </name>
      <telecom>
        <system value="email"/>
        <value value="jdehnbostel@computablepublishing.com"/>
      </telecom>
    </Practitioner>
  </contained>
  <contained>
    <Practitioner>
      <id value="contributor2"/>
      <name>
        <family value="Shahin"/>
        <given value="Khalid"/>
      </name>
      <telecom>
        <system value="email"/>
        <value value="kshahin@computablepublishing.com"/>
      </telecom>
    </Practitioner>
  </contained>
  <extension
             url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
    <valueCodeableConcept>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
        <code value="active"/>
        <display value="Active"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <url value="https://fevir.net/resources/Citation/58"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net/FOI"/>
    <value value="58"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <title
         value="Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)"/>
  <status value="active"/>
  <date value="2022-01-10T13:29:15.764Z"/>
  <author>
    <name value="Brian S. Alper"/>
  </author>
  <publisher value="Computable Publishing LLC"/>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="support@computablepublishing.com"/>
    </telecom>
  </contact>
  <description
               value="This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
  <useContext>
    <code>
      <system
              value="http://terminology.hl7.org/CodeSystem/citation-classification-type"/>
      <code value="fevir-platform-use"/>
      <display value="FEvIR Platform Use"/>
    </code>
    <valueCodeableConcept>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/citation-artifact-classifier"/>
        <code value="fhir-resource"/>
        <display value="FHIR Resource"/>
      </coding>
    </valueCodeableConcept>
  </useContext>
  <copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
  <summary>
    <style>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/citation-summary-style"/>
        <code value="comppub"/>
        <display value="Computable Publishing"/>
      </coding>
    </style>
    <text
          value="14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors:  Brian S. Alper,  Joanne Dehnbostel,  Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55."/>
  </summary>
  <relatesTo>
    <type value="derived-from"/>
    <targetReference>🔗 
      <reference value="Evidence/55"/>
      <type value="Evidence"/>
      <display
               value="14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)"/>
    </targetReference>
  </relatesTo>
  <citedArtifact>
    <identifier>
      <type>
        <coding>
          <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
          <code value="ACSN"/>
          <display value="Accession ID"/>
        </coding>
        <text value="FEvIR Object Identifier"/>
      </type>
      <system value="https://fevir.net"/>
      <value value="55"/>
      <assigner>
        <display value="Computable Publishing LLC"/>
      </assigner>
    </identifier>
    <dateAccessed value="2021-03-13"/>
    <statusDate>
      <activity>
        <coding>
          <system
                  value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
          <code value="created"/>
          <display value="Created"/>
        </coding>
      </activity>
      <actual value="true"/>
      <period>
        <end value="2020-12-17"/>
      </period>
    </statusDate>
    <title>
      <type>
        <coding>
          <system value="http://terminology.hl7.org/CodeSystem/title-type"/>
          <code value="primary"/>
          <display value="Primary title"/>
        </coding>
      </type>
      <text
            value="14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)."/>
    </title>
    <abstract>
      <type>
        <coding>
          <system
                  value="http://terminology.hl7.org/CodeSystem/cited-artifact-abstract-type"/>
          <code value="primary-human-use"/>
          <display value="Primary human use"/>
        </coding>
      </type>
      <text
            value="COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis"/>
      <copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
    </abstract>
    <publicationForm>
      <publishedIn>
        <type>
          <coding>
            <system
                    value="http://terminology.hl7.org/CodeSystem/published-in-type"/>
            <code value="D019991"/>
            <display value="Database"/>
          </coding>
        </type>
        <title
               value="Fast Evidence Interoperability Resources (FEvIR) Platform"/>
        <publisher>
          <type value="Organization"/>
          <display value="Computable Publishing LLC"/>
        </publisher>
        <publisherLocation value="Ipswich, MA, USA"/>
      </publishedIn>
      <lastRevisionDate value="2020-12-21"/>
      <copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
    </publicationForm>
    <webLocation>
      <classifier>
        <coding>
          <system
                  value="http://terminology.hl7.org/CodeSystem/artifact-url-classifier"/>
          <code value="json"/>
          <display value="JSON"/>
        </coding>
      </classifier>
      <classifier>
        <coding>
          <system
                  value="http://terminology.hl7.org/CodeSystem/artifact-url-classifier"/>
          <code value="computable-resource"/>
          <display value="Computable resource"/>
        </coding>
      </classifier>
      <url value="https://fevir.net/resources/Evidence/55"/>
    </webLocation>
    <classification>
      <type>
        <coding>
          <system
                  value="http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type"/>
          <code value="knowledge-artifact-type"/>
          <display value="Knowledge Artifact Type"/>
        </coding>
      </type>
      <classifier>
        <coding>
          <system
                  value="http://terminology.hl7.org/CodeSystem/citation-artifact-classifier"/>
          <code value="fhir-resource"/>
          <display value="FHIR Resource"/>
        </coding>
      </classifier>
    </classification>
    <classification>
      <type>
        <text value="fhir-resource"/>
      </type>
      <classifier>
        <coding>
          <system value="http://hl7.org/fhir/fhir-types"/>
          <code value="Evidence"/>
          <display value="Evidence"/>
        </coding>
      </classifier>
    </classification>
    <classification>
      <type>
        <text value="defined-in-text"/>
      </type>
      <classifier>
        <coding>
          <system value="https://fevir.net/resources/CodeSystem/179423"/>
          <code value="defined-in-text"/>
          <display value="Defined in text"/>
        </coding>
        <text value="remdesivir"/>
      </classifier>
      <classifier>
        <coding>
          <system value="https://fevir.net/resources/CodeSystem/179423"/>
          <code value="defined-in-text"/>
          <display value="Defined in text"/>
        </coding>
        <text value="COVID-19"/>
      </classifier>
      <classifier>
        <coding>
          <system value="https://fevir.net/resources/CodeSystem/179423"/>
          <code value="defined-in-text"/>
          <display value="Defined in text"/>
        </coding>
        <text value="pharmaceutical treatment"/>
      </classifier>
    </classification>
    <contributorship>
      <complete value="true"/>
      <entry>
        <contributor>
          <reference value="#contributor0"/>
          <type value="Practitioner"/>
        </contributor>
        <forenameInitials value="BS"/>
        <affiliation>
          <display value="Computable Publishing LLC"/>
        </affiliation>
        <contributionType>
          <coding>
            <system value="http://hl7.org/fhir/artifact-contribution-type"/>
            <code value="conceptualization"/>
            <display value="Conceptualization"/>
          </coding>
        </contributionType>
        <contributionType>
          <coding>
            <system value="http://hl7.org/fhir/artifact-contribution-type"/>
            <code value="data-curation"/>
            <display value="Data curation"/>
          </coding>
        </contributionType>
        <contributionType>
          <coding>
            <system value="http://hl7.org/fhir/artifact-contribution-type"/>
            <code value="supervision"/>
            <display value="Supervision"/>
          </coding>
        </contributionType>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/contributor-role"/>
            <code value="author"/>
            <display value="Author/Creator"/>
          </coding>
        </role>
        <correspondingContact value="true"/>
      </entry>
      <entry>
        <contributor>
          <reference value="#contributor1"/>
          <type value="Practitioner"/>
        </contributor>
        <forenameInitials value="J"/>
        <affiliation>
          <display value="Computable Publishing LLC"/>
        </affiliation>
        <contributionType>
          <coding>
            <system value="http://hl7.org/fhir/artifact-contribution-type"/>
            <code value="formal-analysis"/>
            <display value="Formal analysis"/>
          </coding>
        </contributionType>
        <contributionType>
          <coding>
            <system value="http://hl7.org/fhir/artifact-contribution-type"/>
            <code value="data-curation"/>
            <display value="Data curation"/>
          </coding>
        </contributionType>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/contributor-role"/>
            <code value="author"/>
            <display value="Author/Creator"/>
          </coding>
        </role>
        <correspondingContact value="false"/>
      </entry>
      <entry>
        <contributor>
          <reference value="#contributor2"/>
          <type value="Practitioner"/>
        </contributor>
        <forenameInitials value="K"/>
        <affiliation>
          <display value="Computable Publishing LLC"/>
        </affiliation>
        <contributionType>
          <coding>
            <system value="http://hl7.org/fhir/artifact-contribution-type"/>
            <code value="software"/>
            <display value="Software"/>
          </coding>
        </contributionType>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/contributor-role"/>
            <code value="author"/>
            <display value="Author/Creator"/>
          </coding>
        </role>
        <correspondingContact value="false"/>
      </entry>
    </contributorship>
  </citedArtifact>
</Citation>